INDEPENDENT PRACTICE RESOURCE • UNOFFICIAL
RN Pharmacology Proctored Exam 2026/2027
250 Questions, Answers & Rationales | Independent Practice Edition
ORIGINAL • UNOFFICIAL • NOT AUTHENTICATED OR AFFILIATED WITH ATI OR NCLEX
Section 1: Brief Introduction
This independent pharmacology practice resource contains 250 original questions with
integrated answers and rationales across medication principles, administration safety, major
drug classes, lifespan considerations, calculations, and patient education. It is not an
authenticated, official, or affiliated ATI/NCLEX examination and does not claim to reproduce
proprietary exam questions.
Section 2: The Complete Exam
Instructions: Select the single best answer. The correct option is shown in cyan bold, followed by a brief rationale. The
questions are original study items and are not actual secured proctored-exam questions.
Medication safety note: Dose-calculation orders are fictional and provided only to test arithmetic; they are
not treatment recommendations and do not establish that an order is clinically appropriate. In practice,
verify the current prescription, patient, indication, allergies, measured weight and units,
concentration/formulation, dose limits, organ function, interactions, and local policy using current
authoritative references and an appropriately qualified clinician/pharmacist. The references below are
predominantly U.S.-based; learners practicing in Kenya should follow current Ministry of Health, Pharmacy
and Poisons Board, and facility requirements where applicable.
1. A medication crosses cell membranes by passive diffusion. Which drug characteristic
generally favors this process?
A. Strong binding to an insoluble carrier.
B. Lipid solubility in the nonionized form.
C. A large molecular size with high polarity.
D. Permanent ionization at physiologic pH.
Rationale: Lipid-soluble, nonionized molecules generally cross membranes more readily by passive
diffusion. Actual absorption also depends on formulation, surface area, blood flow, and route. [R4]
2. A patient takes an oral drug with extensive first-pass metabolism. What does this mean?
A. A substantial fraction may be metabolized in the gut wall or liver before reaching
systemic circulation.
B. The drug is eliminated only through the lungs.
C. The medication is absorbed directly into bone.
D. The drug bypasses the liver completely.
Rationale: Orally absorbed drugs may pass through the intestinal wall and liver before entering
systemic circulation, reducing bioavailability. Route and formulation can therefore alter systemic
exposure. [R4]
3. A highly protein-bound medication is given to a patient with severe hypoalbuminemia.
What is a potential concern?
A. The free, pharmacologically active fraction may increase, raising toxicity risk.
B. The medication cannot be absorbed by any route.
Pharmacology study resource | Page 1
, INDEPENDENT PRACTICE RESOURCE • UNOFFICIAL
C. All drug will become inactive immediately.
D. The drug will be eliminated only in stool.
Rationale: Only unbound drug is generally available to interact with receptors and be cleared, so
lower albumin can increase free fraction for some drugs. Clinical effect depends on distribution and
clearance as well. [R4,R30]
4. Which organ system is most responsible for metabolism of many medications?
A. The spleen exclusively.
B. The skin exclusively.
C. The liver.
D. The gallbladder only.
Rationale: The liver is a major site of metabolism, although other tissues and enzymes also
contribute. Hepatic impairment can alter drug exposure and may require review of product-specific
guidance. [R4]
5. A drug has a long elimination half-life. Which statement is most accurate?
A. The drug always produces a stronger effect.
B. The medication must be administered every hour.
C. It takes longer for the plasma concentration to decline by about one-half after
elimination begins.
D. The drug is never metabolized.
Rationale: Half-life describes the time for plasma concentration to decrease by roughly 50% in the
relevant elimination phase. It helps inform duration and accumulation but does not alone determine
a regimen. [R4]
6. A patient with reduced kidney function receives a renally cleared medication. What
should the nurse do?
A. Stop all medications permanently.
B. Independently double the interval without an order.
C. Assume renal disease has no effect on medication exposure.
D. Review renal function and clarify whether the prescribed regimen is appropriate
using current references and the care team.
Rationale: Reduced renal clearance can increase exposure to some drugs; dose or interval decisions
are drug-specific and require prescriber/pharmacist review. Do not independently change an order.
[R30]
7. A patient takes a medication that induces a hepatic enzyme. What may occur with a
second substrate medication?
A. It will become a vitamin.
B. Its concentration or effect may decrease as metabolism increases.
C. Its concentration must increase in every case.
D. It can no longer be absorbed from any route.
Rationale: Enzyme induction can increase metabolism of susceptible substrates and reduce
exposure, though clinical effects vary by drug and timing. Check a current interaction reference
before acting. [R4,R29]
Pharmacology study resource | Page 2
, INDEPENDENT PRACTICE RESOURCE • UNOFFICIAL
8. A patient takes a strong enzyme inhibitor with a narrow-therapeutic-index drug. What is
the priority?
A. Double the narrow-index dose.
B. Reassure the patient that interactions only affect vitamins.
C. Tell the patient to stop both medicines without guidance.
D. Assess for toxicity and promptly consult the prescriber or pharmacist about the
interaction and monitoring.
Rationale: Enzyme inhibition can raise concentrations of susceptible medications, and narrow
therapeutic index drugs have less margin for error. Prompt medication review and monitoring are
appropriate. [R2,R29]
9. A medication is a competitive antagonist at a receptor. What does it generally do?
A. Irreversibly creates more receptors in every tissue.
B. Competes with an agonist for receptor binding and reduces receptor activation.
C. Acts as a substrate for DNA replication.
D. Guarantees the agonist will have a longer half-life.
Rationale: A competitive antagonist occupies receptor sites and can reduce agonist response; the
effect may be overcome by higher agonist concentrations depending on the system. Assess the
patient’s response and report clinically significant changes according to the care plan. [R2,R3,R4]
[R4]
10. A partial agonist binds a receptor with high affinity. Which effect is expected when it
replaces a full agonist?
A. It prevents all drug metabolism.
B. It always produces a greater maximal response than a full agonist.
C. It has no receptor activity under any condition.
D. It can produce a smaller maximal response while occupying the receptor.
Rationale: A partial agonist activates a receptor but has lower intrinsic efficacy than a full agonist.
In the presence of a full agonist, it can also reduce the overall response. [R4]
11. A patient develops tolerance to a medication. Which statement best describes
tolerance?
A. A reduced response after repeated exposure may lead to a need for clinical
reassessment.
B. A guarantee that the medication is ineffective for everyone.
C. An immediate allergic reaction to the first dose.
D. A permanent inability to eliminate any medication.
Rationale: Tolerance is a diminished response after repeated exposure and is distinct from allergy or
physical dependence. Dose changes should be clinician-directed and consider safety, indication, and
alternatives. [R4,R27]
12. A patient says they have taken a sedative every day for months and asks to stop today.
What is the safest response?
Pharmacology study resource | Page 3
, INDEPENDENT PRACTICE RESOURCE • UNOFFICIAL
A. Stop immediately because dependence is impossible.
B. Contact the prescriber before stopping because abrupt discontinuation may cause
withdrawal or rebound effects.
C. Take double doses for two days and then stop.
D. Share the medication with a family member.
Rationale: Some sedatives can produce physical dependence, and abrupt discontinuation may be
dangerous. Any taper or change must be individualized by the prescriber. [R15]
13. A patient develops hives and wheezing minutes after a medication. Which response is
most appropriate?
A. Treat as a possible severe hypersensitivity reaction and activate the emergency
response.
B. Document a routine expected side effect and give the next dose.
C. Wait until tomorrow to assess breathing.
D. Recommend taking another dose with food.
Rationale: Hives with wheezing can indicate anaphylaxis, not a routine side effect. Stop exposure
and provide emergency care according to protocol. [R3]
14. A patient reports nausea after starting a medication but has no rash, swelling, or
breathing difficulty. How should the nurse classify this initially?
A. A medication allergy in every case.
B. Proof of intentional overdose.
C. A possible adverse effect that should be assessed and compared with the medication
information.
D. Anaphylaxis by definition.
Rationale: Nausea may be an adverse effect and warrants assessment of severity, timing, hydration,
and other causes. Allergy labeling should be based on the reaction history rather than assumed. [R3]
15. A medication has a narrow therapeutic index. What is the key implication?
A. Small concentration changes may cause loss of effect or toxicity, so monitoring and
interaction review matter.
B. It cannot interact with other medications.
C. It is suitable for self-adjustment by the patient.
D. It is always safe to take without monitoring.
Rationale: Narrow therapeutic index drugs have a limited separation between effective and toxic
concentrations. Follow prescribed monitoring and consult current references for interactions and
organ-function changes. [R2,R4]
16. A patient asks why an extended-release tablet must not be crushed. What is the best
response?
A. Crushing can disrupt controlled release and cause dose dumping or altered
absorption.
B. The active ingredient would be removed by crushing.
C. The tablet would become an injectable product.
D. Crushing always makes it safer for the stomach.
Pharmacology study resource | Page 4
RN Pharmacology Proctored Exam 2026/2027
250 Questions, Answers & Rationales | Independent Practice Edition
ORIGINAL • UNOFFICIAL • NOT AUTHENTICATED OR AFFILIATED WITH ATI OR NCLEX
Section 1: Brief Introduction
This independent pharmacology practice resource contains 250 original questions with
integrated answers and rationales across medication principles, administration safety, major
drug classes, lifespan considerations, calculations, and patient education. It is not an
authenticated, official, or affiliated ATI/NCLEX examination and does not claim to reproduce
proprietary exam questions.
Section 2: The Complete Exam
Instructions: Select the single best answer. The correct option is shown in cyan bold, followed by a brief rationale. The
questions are original study items and are not actual secured proctored-exam questions.
Medication safety note: Dose-calculation orders are fictional and provided only to test arithmetic; they are
not treatment recommendations and do not establish that an order is clinically appropriate. In practice,
verify the current prescription, patient, indication, allergies, measured weight and units,
concentration/formulation, dose limits, organ function, interactions, and local policy using current
authoritative references and an appropriately qualified clinician/pharmacist. The references below are
predominantly U.S.-based; learners practicing in Kenya should follow current Ministry of Health, Pharmacy
and Poisons Board, and facility requirements where applicable.
1. A medication crosses cell membranes by passive diffusion. Which drug characteristic
generally favors this process?
A. Strong binding to an insoluble carrier.
B. Lipid solubility in the nonionized form.
C. A large molecular size with high polarity.
D. Permanent ionization at physiologic pH.
Rationale: Lipid-soluble, nonionized molecules generally cross membranes more readily by passive
diffusion. Actual absorption also depends on formulation, surface area, blood flow, and route. [R4]
2. A patient takes an oral drug with extensive first-pass metabolism. What does this mean?
A. A substantial fraction may be metabolized in the gut wall or liver before reaching
systemic circulation.
B. The drug is eliminated only through the lungs.
C. The medication is absorbed directly into bone.
D. The drug bypasses the liver completely.
Rationale: Orally absorbed drugs may pass through the intestinal wall and liver before entering
systemic circulation, reducing bioavailability. Route and formulation can therefore alter systemic
exposure. [R4]
3. A highly protein-bound medication is given to a patient with severe hypoalbuminemia.
What is a potential concern?
A. The free, pharmacologically active fraction may increase, raising toxicity risk.
B. The medication cannot be absorbed by any route.
Pharmacology study resource | Page 1
, INDEPENDENT PRACTICE RESOURCE • UNOFFICIAL
C. All drug will become inactive immediately.
D. The drug will be eliminated only in stool.
Rationale: Only unbound drug is generally available to interact with receptors and be cleared, so
lower albumin can increase free fraction for some drugs. Clinical effect depends on distribution and
clearance as well. [R4,R30]
4. Which organ system is most responsible for metabolism of many medications?
A. The spleen exclusively.
B. The skin exclusively.
C. The liver.
D. The gallbladder only.
Rationale: The liver is a major site of metabolism, although other tissues and enzymes also
contribute. Hepatic impairment can alter drug exposure and may require review of product-specific
guidance. [R4]
5. A drug has a long elimination half-life. Which statement is most accurate?
A. The drug always produces a stronger effect.
B. The medication must be administered every hour.
C. It takes longer for the plasma concentration to decline by about one-half after
elimination begins.
D. The drug is never metabolized.
Rationale: Half-life describes the time for plasma concentration to decrease by roughly 50% in the
relevant elimination phase. It helps inform duration and accumulation but does not alone determine
a regimen. [R4]
6. A patient with reduced kidney function receives a renally cleared medication. What
should the nurse do?
A. Stop all medications permanently.
B. Independently double the interval without an order.
C. Assume renal disease has no effect on medication exposure.
D. Review renal function and clarify whether the prescribed regimen is appropriate
using current references and the care team.
Rationale: Reduced renal clearance can increase exposure to some drugs; dose or interval decisions
are drug-specific and require prescriber/pharmacist review. Do not independently change an order.
[R30]
7. A patient takes a medication that induces a hepatic enzyme. What may occur with a
second substrate medication?
A. It will become a vitamin.
B. Its concentration or effect may decrease as metabolism increases.
C. Its concentration must increase in every case.
D. It can no longer be absorbed from any route.
Rationale: Enzyme induction can increase metabolism of susceptible substrates and reduce
exposure, though clinical effects vary by drug and timing. Check a current interaction reference
before acting. [R4,R29]
Pharmacology study resource | Page 2
, INDEPENDENT PRACTICE RESOURCE • UNOFFICIAL
8. A patient takes a strong enzyme inhibitor with a narrow-therapeutic-index drug. What is
the priority?
A. Double the narrow-index dose.
B. Reassure the patient that interactions only affect vitamins.
C. Tell the patient to stop both medicines without guidance.
D. Assess for toxicity and promptly consult the prescriber or pharmacist about the
interaction and monitoring.
Rationale: Enzyme inhibition can raise concentrations of susceptible medications, and narrow
therapeutic index drugs have less margin for error. Prompt medication review and monitoring are
appropriate. [R2,R29]
9. A medication is a competitive antagonist at a receptor. What does it generally do?
A. Irreversibly creates more receptors in every tissue.
B. Competes with an agonist for receptor binding and reduces receptor activation.
C. Acts as a substrate for DNA replication.
D. Guarantees the agonist will have a longer half-life.
Rationale: A competitive antagonist occupies receptor sites and can reduce agonist response; the
effect may be overcome by higher agonist concentrations depending on the system. Assess the
patient’s response and report clinically significant changes according to the care plan. [R2,R3,R4]
[R4]
10. A partial agonist binds a receptor with high affinity. Which effect is expected when it
replaces a full agonist?
A. It prevents all drug metabolism.
B. It always produces a greater maximal response than a full agonist.
C. It has no receptor activity under any condition.
D. It can produce a smaller maximal response while occupying the receptor.
Rationale: A partial agonist activates a receptor but has lower intrinsic efficacy than a full agonist.
In the presence of a full agonist, it can also reduce the overall response. [R4]
11. A patient develops tolerance to a medication. Which statement best describes
tolerance?
A. A reduced response after repeated exposure may lead to a need for clinical
reassessment.
B. A guarantee that the medication is ineffective for everyone.
C. An immediate allergic reaction to the first dose.
D. A permanent inability to eliminate any medication.
Rationale: Tolerance is a diminished response after repeated exposure and is distinct from allergy or
physical dependence. Dose changes should be clinician-directed and consider safety, indication, and
alternatives. [R4,R27]
12. A patient says they have taken a sedative every day for months and asks to stop today.
What is the safest response?
Pharmacology study resource | Page 3
, INDEPENDENT PRACTICE RESOURCE • UNOFFICIAL
A. Stop immediately because dependence is impossible.
B. Contact the prescriber before stopping because abrupt discontinuation may cause
withdrawal or rebound effects.
C. Take double doses for two days and then stop.
D. Share the medication with a family member.
Rationale: Some sedatives can produce physical dependence, and abrupt discontinuation may be
dangerous. Any taper or change must be individualized by the prescriber. [R15]
13. A patient develops hives and wheezing minutes after a medication. Which response is
most appropriate?
A. Treat as a possible severe hypersensitivity reaction and activate the emergency
response.
B. Document a routine expected side effect and give the next dose.
C. Wait until tomorrow to assess breathing.
D. Recommend taking another dose with food.
Rationale: Hives with wheezing can indicate anaphylaxis, not a routine side effect. Stop exposure
and provide emergency care according to protocol. [R3]
14. A patient reports nausea after starting a medication but has no rash, swelling, or
breathing difficulty. How should the nurse classify this initially?
A. A medication allergy in every case.
B. Proof of intentional overdose.
C. A possible adverse effect that should be assessed and compared with the medication
information.
D. Anaphylaxis by definition.
Rationale: Nausea may be an adverse effect and warrants assessment of severity, timing, hydration,
and other causes. Allergy labeling should be based on the reaction history rather than assumed. [R3]
15. A medication has a narrow therapeutic index. What is the key implication?
A. Small concentration changes may cause loss of effect or toxicity, so monitoring and
interaction review matter.
B. It cannot interact with other medications.
C. It is suitable for self-adjustment by the patient.
D. It is always safe to take without monitoring.
Rationale: Narrow therapeutic index drugs have a limited separation between effective and toxic
concentrations. Follow prescribed monitoring and consult current references for interactions and
organ-function changes. [R2,R4]
16. A patient asks why an extended-release tablet must not be crushed. What is the best
response?
A. Crushing can disrupt controlled release and cause dose dumping or altered
absorption.
B. The active ingredient would be removed by crushing.
C. The tablet would become an injectable product.
D. Crushing always makes it safer for the stomach.
Pharmacology study resource | Page 4
